nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—BCHE—malignant glioma	0.871	1	CbGaD
Ephedrine—SLC18A2—telencephalic ventricle—malignant glioma	0.00955	0.197	CbGeAlD
Ephedrine—SLC18A2—brainstem—malignant glioma	0.00258	0.0532	CbGeAlD
Ephedrine—ACHE—telencephalon—malignant glioma	0.00235	0.0485	CbGeAlD
Ephedrine—SLC18A2—telencephalon—malignant glioma	0.00229	0.0472	CbGeAlD
Ephedrine—ACHE—medulla oblongata—malignant glioma	0.00185	0.0381	CbGeAlD
Ephedrine—SLC18A2—medulla oblongata—malignant glioma	0.0018	0.0371	CbGeAlD
Ephedrine—Pseudoephedrine—IL2—malignant glioma	0.00171	0.219	CrCbGaD
Ephedrine—ACHE—midbrain—malignant glioma	0.00169	0.0348	CbGeAlD
Ephedrine—ACHE—spinal cord—malignant glioma	0.00165	0.034	CbGeAlD
Ephedrine—SLC18A2—midbrain—malignant glioma	0.00165	0.0339	CbGeAlD
Ephedrine—SLC6A2—brainstem—malignant glioma	0.00158	0.0325	CbGeAlD
Ephedrine—ADRA1A—brainstem—malignant glioma	0.00147	0.0302	CbGeAlD
Ephedrine—SLC6A2—telencephalon—malignant glioma	0.0014	0.0288	CbGeAlD
Ephedrine—ACHE—cerebellum—malignant glioma	0.00131	0.0269	CbGeAlD
Ephedrine—SLC18A2—central nervous system—malignant glioma	0.0013	0.0269	CbGeAlD
Ephedrine—BCHE—brainstem—malignant glioma	0.0013	0.0268	CbGeAlD
Ephedrine—ADRA1A—telencephalon—malignant glioma	0.0013	0.0268	CbGeAlD
Ephedrine—Cerebral haemorrhage—Carmustine—malignant glioma	0.00128	0.0889	CcSEcCtD
Ephedrine—SLC18A2—cerebellum—malignant glioma	0.00127	0.0262	CbGeAlD
Ephedrine—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00124	0.0859	CcSEcCtD
Ephedrine—BCHE—telencephalon—malignant glioma	0.00116	0.0238	CbGeAlD
Ephedrine—SLC6A2—medulla oblongata—malignant glioma	0.0011	0.0227	CbGeAlD
Ephedrine—ACHE—brain—malignant glioma	0.00106	0.0219	CbGeAlD
Ephedrine—Paranoia—Carmustine—malignant glioma	0.00104	0.0722	CcSEcCtD
Ephedrine—SLC18A2—brain—malignant glioma	0.00104	0.0213	CbGeAlD
Ephedrine—BCHE—medulla oblongata—malignant glioma	0.000909	0.0187	CbGeAlD
Ephedrine—BCHE—midbrain—malignant glioma	0.000831	0.0171	CbGeAlD
Ephedrine—BCHE—spinal cord—malignant glioma	0.000811	0.0167	CbGeAlD
Ephedrine—SLC6A2—central nervous system—malignant glioma	0.000796	0.0164	CbGeAlD
Ephedrine—Benzyl alcohol—CYP2B6—malignant glioma	0.000742	0.095	CrCbGaD
Ephedrine—ADRA1A—central nervous system—malignant glioma	0.00074	0.0152	CbGeAlD
Ephedrine—Phenylpropanolamine—SLC6A3—malignant glioma	0.000736	0.0942	CrCbGaD
Ephedrine—ADRA1A—cerebellum—malignant glioma	0.000723	0.0149	CbGeAlD
Ephedrine—Selegiline—CYP2B6—malignant glioma	0.000712	0.0911	CrCbGaD
Ephedrine—BCHE—central nervous system—malignant glioma	0.000658	0.0135	CbGeAlD
Ephedrine—Phentermine—SLC6A3—malignant glioma	0.000656	0.0839	CrCbGaD
Ephedrine—BCHE—cerebellum—malignant glioma	0.000643	0.0132	CbGeAlD
Ephedrine—SLC6A2—brain—malignant glioma	0.000632	0.013	CbGeAlD
Ephedrine—Dextroamphetamine—SLC6A3—malignant glioma	0.000625	0.0801	CrCbGaD
Ephedrine—Pseudoephedrine—SLC6A3—malignant glioma	0.000622	0.0796	CrCbGaD
Ephedrine—ADRA1A—brain—malignant glioma	0.000587	0.0121	CbGeAlD
Ephedrine—Pseudoephedrine—TNF—malignant glioma	0.000577	0.0739	CrCbGaD
Ephedrine—BCHE—brain—malignant glioma	0.000522	0.0108	CbGeAlD
Ephedrine—Amphetamine—SLC6A3—malignant glioma	0.000504	0.0645	CrCbGaD
Ephedrine—Methamphetamine—SLC6A3—malignant glioma	0.000467	0.0598	CrCbGaD
Ephedrine—Atomoxetine—SLC6A3—malignant glioma	0.00046	0.0589	CrCbGaD
Ephedrine—Dysuria—Temozolomide—malignant glioma	0.000403	0.0279	CcSEcCtD
Ephedrine—Hallucination—Carmustine—malignant glioma	0.000355	0.0246	CcSEcCtD
Ephedrine—Hallucination—Temozolomide—malignant glioma	0.000343	0.0238	CcSEcCtD
Ephedrine—Arrhythmia—Carmustine—malignant glioma	0.000319	0.0221	CcSEcCtD
Ephedrine—Tremor—Carmustine—malignant glioma	0.000291	0.0201	CcSEcCtD
Ephedrine—Agitation—Carmustine—malignant glioma	0.000285	0.0198	CcSEcCtD
Ephedrine—Tremor—Temozolomide—malignant glioma	0.000281	0.0195	CcSEcCtD
Ephedrine—Agitation—Temozolomide—malignant glioma	0.000276	0.0191	CcSEcCtD
Ephedrine—Vertigo—Temozolomide—malignant glioma	0.000269	0.0187	CcSEcCtD
Ephedrine—Hypertension—Carmustine—malignant glioma	0.000268	0.0186	CcSEcCtD
Ephedrine—Palpitations—Temozolomide—malignant glioma	0.000265	0.0184	CcSEcCtD
Ephedrine—Chest pain—Carmustine—malignant glioma	0.000264	0.0183	CcSEcCtD
Ephedrine—Anxiety—Carmustine—malignant glioma	0.000263	0.0182	CcSEcCtD
Ephedrine—Hypertension—Temozolomide—malignant glioma	0.000259	0.0179	CcSEcCtD
Ephedrine—Confusional state—Carmustine—malignant glioma	0.000255	0.0177	CcSEcCtD
Ephedrine—Anxiety—Temozolomide—malignant glioma	0.000254	0.0176	CcSEcCtD
Ephedrine—Tachycardia—Carmustine—malignant glioma	0.000247	0.0171	CcSEcCtD
Ephedrine—Confusional state—Temozolomide—malignant glioma	0.000247	0.0171	CcSEcCtD
Ephedrine—Anorexia—Carmustine—malignant glioma	0.000241	0.0167	CcSEcCtD
Ephedrine—Hyperhidrosis—Temozolomide—malignant glioma	0.000237	0.0164	CcSEcCtD
Ephedrine—Anorexia—Temozolomide—malignant glioma	0.000233	0.0162	CcSEcCtD
Ephedrine—Insomnia—Carmustine—malignant glioma	0.000229	0.0159	CcSEcCtD
Ephedrine—Dyspnoea—Carmustine—malignant glioma	0.000226	0.0156	CcSEcCtD
Ephedrine—Insomnia—Temozolomide—malignant glioma	0.000221	0.0153	CcSEcCtD
Ephedrine—Decreased appetite—Carmustine—malignant glioma	0.00022	0.0153	CcSEcCtD
Ephedrine—Dyspnoea—Temozolomide—malignant glioma	0.000218	0.0151	CcSEcCtD
Ephedrine—Pain—Carmustine—malignant glioma	0.000217	0.015	CcSEcCtD
Ephedrine—Dyspepsia—Temozolomide—malignant glioma	0.000215	0.0149	CcSEcCtD
Ephedrine—Decreased appetite—Temozolomide—malignant glioma	0.000213	0.0147	CcSEcCtD
Ephedrine—Pain—Temozolomide—malignant glioma	0.000209	0.0145	CcSEcCtD
Ephedrine—Feeling abnormal—Carmustine—malignant glioma	0.000209	0.0145	CcSEcCtD
Ephedrine—Feeling abnormal—Temozolomide—malignant glioma	0.000202	0.014	CcSEcCtD
Ephedrine—Body temperature increased—Carmustine—malignant glioma	0.0002	0.0139	CcSEcCtD
Ephedrine—Body temperature increased—Temozolomide—malignant glioma	0.000194	0.0134	CcSEcCtD
Ephedrine—Asthenia—Carmustine—malignant glioma	0.000182	0.0126	CcSEcCtD
Ephedrine—Asthenia—Temozolomide—malignant glioma	0.000176	0.0122	CcSEcCtD
Ephedrine—Dizziness—Carmustine—malignant glioma	0.000168	0.0116	CcSEcCtD
Ephedrine—Dizziness—Temozolomide—malignant glioma	0.000162	0.0112	CcSEcCtD
Ephedrine—Vomiting—Carmustine—malignant glioma	0.000161	0.0112	CcSEcCtD
Ephedrine—Rash—Carmustine—malignant glioma	0.00016	0.0111	CcSEcCtD
Ephedrine—Dermatitis—Carmustine—malignant glioma	0.00016	0.0111	CcSEcCtD
Ephedrine—Headache—Carmustine—malignant glioma	0.000159	0.011	CcSEcCtD
Ephedrine—Vomiting—Temozolomide—malignant glioma	0.000156	0.0108	CcSEcCtD
Ephedrine—Rash—Temozolomide—malignant glioma	0.000154	0.0107	CcSEcCtD
Ephedrine—Dermatitis—Temozolomide—malignant glioma	0.000154	0.0107	CcSEcCtD
Ephedrine—Headache—Temozolomide—malignant glioma	0.000153	0.0106	CcSEcCtD
Ephedrine—Nausea—Carmustine—malignant glioma	0.00015	0.0104	CcSEcCtD
Ephedrine—Nausea—Temozolomide—malignant glioma	0.000145	0.0101	CcSEcCtD
Ephedrine—ADRB2—GPCR downstream signaling—BDKRB2—malignant glioma	4.31e-05	0.000737	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCR3—malignant glioma	4.28e-05	0.000732	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.27e-05	0.00073	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.18e-05	0.000715	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	4.15e-05	0.00071	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.12e-05	0.000704	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MDK—malignant glioma	4.06e-05	0.000694	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTT1—malignant glioma	4.02e-05	0.000687	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—KNG1—malignant glioma	3.92e-05	0.000671	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—BDKRB2—malignant glioma	3.92e-05	0.00067	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.9e-05	0.000667	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCR3—malignant glioma	3.9e-05	0.000667	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DTX1—malignant glioma	3.87e-05	0.000662	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—F2—malignant glioma	3.85e-05	0.000659	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.81e-05	0.000651	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS1—malignant glioma	3.77e-05	0.000644	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.75e-05	0.000642	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SUFU—malignant glioma	3.72e-05	0.000636	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—F2—malignant glioma	3.71e-05	0.000635	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HEY2—malignant glioma	3.68e-05	0.000628	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.67e-05	0.000628	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GFAP—malignant glioma	3.59e-05	0.000614	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTT1—malignant glioma	3.58e-05	0.000613	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—BDKRB2—malignant glioma	3.57e-05	0.00061	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KNG1—malignant glioma	3.56e-05	0.000609	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCR3—malignant glioma	3.54e-05	0.000606	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—BCHE—malignant glioma	3.5e-05	0.000599	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPHK1—malignant glioma	3.47e-05	0.000594	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC5A5—malignant glioma	3.46e-05	0.000591	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—F2—malignant glioma	3.44e-05	0.000588	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	3.43e-05	0.000587	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR4—malignant glioma	3.4e-05	0.000582	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HEY1—malignant glioma	3.4e-05	0.000582	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	3.39e-05	0.00058	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS1—malignant glioma	3.36e-05	0.000574	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.35e-05	0.000572	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIST1H3B—malignant glioma	3.31e-05	0.000565	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—PIK3CA—malignant glioma	3.29e-05	0.000562	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.27e-05	0.000559	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP2—malignant glioma	3.27e-05	0.000559	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—KNG1—malignant glioma	3.24e-05	0.000555	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.24e-05	0.000554	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—BDKRB2—malignant glioma	3.24e-05	0.000554	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	3.2e-05	0.000548	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—malignant glioma	3.16e-05	0.000541	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MMP3—malignant glioma	3.16e-05	0.00054	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.15e-05	0.000538	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC5A5—malignant glioma	3.08e-05	0.000527	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SUFU—malignant glioma	3.08e-05	0.000526	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HEY2—malignant glioma	3.04e-05	0.00052	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAG2—malignant glioma	3.02e-05	0.000516	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GFAP—malignant glioma	2.97e-05	0.000508	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KNG1—malignant glioma	2.95e-05	0.000504	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	2.94e-05	0.000503	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.92e-05	0.000499	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP2—malignant glioma	2.92e-05	0.000498	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.89e-05	0.000494	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPHK1—malignant glioma	2.87e-05	0.000491	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.83e-05	0.000483	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HEY1—malignant glioma	2.81e-05	0.000481	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR4—malignant glioma	2.81e-05	0.000481	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTP1—malignant glioma	2.79e-05	0.000476	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIST1H3B—malignant glioma	2.73e-05	0.000468	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	2.72e-05	0.000464	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAT—malignant glioma	2.71e-05	0.000463	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—malignant glioma	2.62e-05	0.000447	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MMP3—malignant glioma	2.61e-05	0.000446	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NCOR1—malignant glioma	2.56e-05	0.000438	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—H3F3A—malignant glioma	2.55e-05	0.000437	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—F2—malignant glioma	2.54e-05	0.000434	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCR3—malignant glioma	2.53e-05	0.000432	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.52e-05	0.000431	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAG2—malignant glioma	2.5e-05	0.000427	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—malignant glioma	2.48e-05	0.000425	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK2—malignant glioma	2.46e-05	0.000421	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—YWHAE—malignant glioma	2.46e-05	0.000421	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FLT1—malignant glioma	2.45e-05	0.000419	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DUSP6—malignant glioma	2.44e-05	0.000417	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	2.43e-05	0.000415	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—malignant glioma	2.42e-05	0.000414	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAT—malignant glioma	2.42e-05	0.000413	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAG1—malignant glioma	2.41e-05	0.000412	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	2.4e-05	0.00041	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FBXW7—malignant glioma	2.36e-05	0.000403	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	2.31e-05	0.000396	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—F2—malignant glioma	2.3e-05	0.000394	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NCOR1—malignant glioma	2.28e-05	0.00039	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	2.22e-05	0.00038	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	2.2e-05	0.000377	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	2.16e-05	0.00037	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	2.15e-05	0.000368	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	2.13e-05	0.000365	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—H3F3A—malignant glioma	2.11e-05	0.000361	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KNG1—malignant glioma	2.1e-05	0.00036	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—F2—malignant glioma	2.1e-05	0.000359	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCR3—malignant glioma	2.09e-05	0.000358	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—malignant glioma	2.09e-05	0.000357	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—YWHAE—malignant glioma	2.03e-05	0.000348	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK2—malignant glioma	2.03e-05	0.000348	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FLT1—malignant glioma	2.03e-05	0.000346	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DUSP6—malignant glioma	2.02e-05	0.000345	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT2—malignant glioma	2.02e-05	0.000345	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—malignant glioma	2.01e-05	0.000343	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK1—malignant glioma	2.01e-05	0.000343	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.99e-05	0.000341	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAG1—malignant glioma	1.99e-05	0.000341	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH3—malignant glioma	1.98e-05	0.000339	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FBXW7—malignant glioma	1.95e-05	0.000334	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	1.94e-05	0.000331	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BDKRB2—malignant glioma	1.91e-05	0.000327	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—F2—malignant glioma	1.9e-05	0.000326	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—malignant glioma	1.9e-05	0.000325	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP3—malignant glioma	1.86e-05	0.000319	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—malignant glioma	1.86e-05	0.000318	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	1.86e-05	0.000318	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	1.85e-05	0.000316	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT2—malignant glioma	1.84e-05	0.000314	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARG—malignant glioma	1.83e-05	0.000314	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—malignant glioma	1.82e-05	0.000312	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTK2—malignant glioma	1.79e-05	0.000307	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTPN11—malignant glioma	1.79e-05	0.000306	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	1.79e-05	0.000306	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH2—malignant glioma	1.78e-05	0.000304	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.78e-05	0.000304	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—malignant glioma	1.76e-05	0.000302	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HES1—malignant glioma	1.76e-05	0.000301	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NCOR1—malignant glioma	1.75e-05	0.0003	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KNG1—malignant glioma	1.74e-05	0.000298	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RAF1—malignant glioma	1.73e-05	0.000296	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—malignant glioma	1.71e-05	0.000292	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—malignant glioma	1.7e-05	0.00029	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	1.69e-05	0.000289	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	1.68e-05	0.000287	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—malignant glioma	1.67e-05	0.000286	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	1.67e-05	0.000285	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	1.66e-05	0.000284	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARG—malignant glioma	1.64e-05	0.00028	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPP1—malignant glioma	1.63e-05	0.000279	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	1.62e-05	0.000277	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	1.6e-05	0.000274	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—malignant glioma	1.55e-05	0.000265	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—malignant glioma	1.54e-05	0.000264	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP3—malignant glioma	1.54e-05	0.000264	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	1.54e-05	0.000263	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	1.53e-05	0.000261	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFB—malignant glioma	1.51e-05	0.000258	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR1—malignant glioma	1.5e-05	0.000257	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—malignant glioma	1.49e-05	0.000255	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTK2—malignant glioma	1.48e-05	0.000254	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	1.48e-05	0.000253	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—malignant glioma	1.48e-05	0.000253	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HES1—malignant glioma	1.46e-05	0.000249	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—malignant glioma	1.46e-05	0.000249	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	1.45e-05	0.000248	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—malignant glioma	1.44e-05	0.000247	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	1.43e-05	0.000245	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—malignant glioma	1.43e-05	0.000244	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KDR—malignant glioma	1.41e-05	0.000242	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	1.41e-05	0.000242	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	1.4e-05	0.000239	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	1.39e-05	0.000237	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FN1—malignant glioma	1.36e-05	0.000233	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—F2—malignant glioma	1.36e-05	0.000233	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPP1—malignant glioma	1.35e-05	0.000231	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BAD—malignant glioma	1.34e-05	0.00023	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	1.34e-05	0.000229	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	1.33e-05	0.000228	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD80—malignant glioma	1.3e-05	0.000223	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	1.3e-05	0.000223	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APC—malignant glioma	1.3e-05	0.000223	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—malignant glioma	1.3e-05	0.000222	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—malignant glioma	1.29e-05	0.00022	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGF—malignant glioma	1.29e-05	0.00022	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—malignant glioma	1.28e-05	0.000219	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTPN11—malignant glioma	1.28e-05	0.000219	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—malignant glioma	1.28e-05	0.000219	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—malignant glioma	1.26e-05	0.000215	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	1.25e-05	0.000213	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	1.24e-05	0.000212	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BRAF—malignant glioma	1.22e-05	0.000209	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	1.22e-05	0.000209	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT2—malignant glioma	1.19e-05	0.000204	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—malignant glioma	1.19e-05	0.000203	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—malignant glioma	1.18e-05	0.000202	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KDR—malignant glioma	1.17e-05	0.0002	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	1.14e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	1.13e-05	0.000194	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—F2—malignant glioma	1.13e-05	0.000192	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FN1—malignant glioma	1.13e-05	0.000192	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—malignant glioma	1.12e-05	0.000192	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—malignant glioma	1.12e-05	0.000192	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BAD—malignant glioma	1.11e-05	0.00019	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	1.1e-05	0.000188	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF2—malignant glioma	1.1e-05	0.000187	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD80—malignant glioma	1.08e-05	0.000184	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APC—malignant glioma	1.08e-05	0.000184	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	1.08e-05	0.000184	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGF—malignant glioma	1.06e-05	0.000182	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	1.06e-05	0.000181	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	1.03e-05	0.000176	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MDM2—malignant glioma	1.03e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAF1—malignant glioma	1.02e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BRAF—malignant glioma	1.01e-05	0.000173	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—malignant glioma	1.01e-05	0.000173	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	9.97e-06	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT2—malignant glioma	9.85e-06	0.000168	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	9.81e-06	0.000168	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—malignant glioma	9.58e-06	0.000164	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	9.46e-06	0.000162	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	9.38e-06	0.00016	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	9.27e-06	0.000158	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	9.26e-06	0.000158	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—malignant glioma	9.17e-06	0.000157	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—malignant glioma	9.16e-06	0.000157	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	9.06e-06	0.000155	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—malignant glioma	8.88e-06	0.000152	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—malignant glioma	8.67e-06	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—malignant glioma	8.62e-06	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	8.51e-06	0.000146	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	8.48e-06	0.000145	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	8.45e-06	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	8.41e-06	0.000144	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	8.36e-06	0.000143	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	8.25e-06	0.000141	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	7.93e-06	0.000136	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—malignant glioma	7.92e-06	0.000135	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	7.78e-06	0.000133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—malignant glioma	7.71e-06	0.000132	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	7.66e-06	0.000131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	7.59e-06	0.00013	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—malignant glioma	7.58e-06	0.00013	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—malignant glioma	7.25e-06	0.000124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	7.17e-06	0.000123	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—malignant glioma	7.16e-06	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	7.13e-06	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—malignant glioma	7.01e-06	0.00012	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	6.95e-06	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—malignant glioma	6.62e-06	0.000113	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—malignant glioma	6.47e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	6.44e-06	0.00011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	6.38e-06	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	6.08e-06	0.000104	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—malignant glioma	5.92e-06	0.000101	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—malignant glioma	5.88e-06	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	5.79e-06	9.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	5.47e-06	9.36e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	5.03e-06	8.6e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—malignant glioma	4.97e-06	8.49e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—malignant glioma	4.87e-06	8.32e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	4.11e-06	7.03e-05	CbGpPWpGaD
